Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.
about
Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction.Gene-gene interactions between TGF-β/Smad3 signalling pathway polymorphisms affect susceptibility to knee osteoarthritis.Common germline polymorphisms associated with breast cancer-specific survival.Contribution of TIMP3 polymorphisms to the development of preeclampsia in Han Chinese women.Association of the polymorphisms of MMP-9 and TIMP-3 genes with thoracic aortic dissection in Chinese Han population.Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral CancerTIMP-2 SNPs rs7342880 and rs4789936 are linked to risk of knee osteoarthritis in the Chinese Han Population.Does mammographic density reflect the expression of breast cancer markers?Association between MMP-2 and TIMP-2 gene polymorphisms and advanced-stage endometriosis in Korean women.Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.MMP13 polymorphism decreases risk for dental caries.Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population.Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.Analysis of the association between polymorphisms in MMP2, MMP3, MMP9, MMP20, TIMP1, and TIMP2 genes with white spot lesions and early childhood caries.
P2860
Q34242914-EE3923B4-7308-4C76-BB77-B1595CEF3036Q34634735-08A57BEF-B9D0-4FC7-AF2F-B0DE885FBC7AQ35739981-0837C929-D0EC-45FC-9957-594CA04F651BQ35794653-690492D5-98EE-4B3C-B8C5-E3CA5194D226Q36192139-95948CCA-90C6-48F3-8AC8-42199D9AB320Q36287441-DC908FCA-0D9E-430C-9395-A3B0BD207FCDQ36299328-24F0A599-B142-4492-BFB7-F329FC4CC70AQ37702061-D15F0A39-C551-470B-A852-7B8A11885764Q38101685-A51359E6-7E9D-4CBB-83DF-18F9B6DB7F42Q38458366-09720933-2AA6-4631-8CAE-9D22714F8786Q39790504-2A3AD362-9E84-4F04-B8CD-23C4EDB5445AQ47607004-08D29815-B299-4197-9F7A-88F7182C04C5Q50052994-3EA38235-8CC7-46CF-AD3B-BCE06BA73593Q50863404-3E18C58B-9227-4C9A-8971-FAA94098E778Q53350461-FB299D5A-CB7B-4967-B341-611C62748C2F
P2860
Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polymorphisms in tissue inhibi ...... r susceptibility and survival.
@en
Polymorphisms in tissue inhibi ...... r susceptibility and survival.
@nl
type
label
Polymorphisms in tissue inhibi ...... r susceptibility and survival.
@en
Polymorphisms in tissue inhibi ...... r susceptibility and survival.
@nl
prefLabel
Polymorphisms in tissue inhibi ...... r susceptibility and survival.
@en
Polymorphisms in tissue inhibi ...... r susceptibility and survival.
@nl
P2093
P2860
P356
P1476
Polymorphisms in tissue inhibi ...... r susceptibility and survival.
@en
P2093
Alicia Beeghly-Fadiel
Jirong Long
Neeraja B Peterson
Xiao-ou Shu
P2860
P304
P356
10.1002/IJC.24405
P577
2009-08-01T00:00:00Z